References
- The Commonwealth. Postponement of CHOGM 2020 due to Covid-19 UK: The Commonwealth; 2020 [Available from: https://thecommonwealth.org/media/news/postponement-chogm-2020-due-covid-19.
- The Commonwealth. Commonwealth heads of government to meet in Rwanda: The Commonwealth,; 2019 [Available from: https://thecommonwealth.org/media/news/commonwealth-heads-government-meet-rwanda
- Rutter V, Chan AHY, Tuck C, Bader L, Bates I. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM). London: BioMed Central; 2018. p. 2018.
- Ozawa S, Evans DR, Bessias S, Haynie DG, Yemeke TT, Laing SK, et al. Prevalence and estimated economic burden of substandard and falsified medicines in low-and middle-income countries: a systematic review and meta-analysis. JAMA Netw Open. 2018;1(4):e181662 e.
- Bates I, John C, Seegobin P, Bruno A. An analysis of the global pharmacy workforce capacity trends from 2006 to 2012. Hum Resour Health. 2018;16(1):3.
- World Health Organization. Global strategy on human resources for health: workforce; 2030. p. 2016.
- World Health Organization. Addressing Human Rights as Key to the COVID-19 Response. In WHO. Geneva: WHO; 2020.
- Alexander GC, Qato DM. Ensuring Access to Medications in the US During the COVID-19 Pandemic. JAMA. 2020.
- Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA. 2020.
- United Nations. Shared responsibility, global solidarity: responding to the socio-economic impacts of COVID-19. 2020.
- Commonwealth Secretariat. The Commonwealth 2020 [Available from: http://thecommonwealth.org/.
- National Institute for Health and Care Excellence (NICE) - Medicines Prescribing Centre UK. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. 2015
- Organization WH. Handbook on health inequality monitoring: with a special focus on low-and middle-income countries: World Health Organization. 2013
- Greenhalgh T, Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ (Clinical research ed). 2020. p. 368.
- Ministry of Health. Signature Exempt Prescriptions and remote prescribing. 2020 [Available from: https://www.health.govt.nz/our-work/digital-health/other-digital-health-initiatives/emedicines/new-zealand-eprescription-service/signature-exempt-prescriptions-and-remote-prescribing
- Vodafone. What is M-Pesa? 2020 [Available from: https://www.vodafone.com/what-we-do/services/m-pesa.
- Citi Newsroom. Bawumia launches COVID-19 Tracker App Ghana 2020 [Available from: https://citinewsroom.com/2020/04/bawumia-launches-covid-19-tracker-app/
- Bhatti YA, Prime M, Harris M, Wadge H, McQueen J, Patel H, et al. The search for the holy grail: frugal innovation in healthcare from low-income or middle-income countries for reverse innovation to developed countries. BMJ Innovations. 2017.
- Kovacs Stephanie, Hawes Stephen E, Maley Stephen N, Mosites Emily, Wong Ling, Stergachis Andy. Technologies for Detecting Falsified and Substandard Drugs in Low and Middleincomecountries. PLoS ONE. 2014;9(3):e90601.
- World Health Organization. Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa. World HealthOrganization. 2011. p. 118.
- Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open. 2013;3(8):e002923.
- Newton PN, Bond KC, Adeyeye M, Antignac M, Ashenef A, Awab GR, Bannenberg WJ, Bower J, Breman J, Brock A, Caillet C. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. The Lancet Global Health. 2020.
- World Health Organization. Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19 In: WHO, editor. Medical Product Alert No3/2020. Geneva: WHO; 2020.
- Buckley GJ, Gostin LO. Countering the problem of falsified and substandard drugs: National Academies Press; 2013.
- mPedigree. What We Do – mPedigree | Bringing Quality to Life; 2020 [Available from: https://mpedigree.com/what-we-do/
- The Access and Delivery Partnership. FDA launches Med Safety App to improve health care delivery in Ghana; 2019 [Available from: http://www.adphealth.org/news/66/FDA-launches-Med-Safety-App-to-improve-health-care-delivery-in-Ghana.html
- Zambia Medicines Regulatory Authority - ZAMRA. ZAMRA has launched ADRA, a new mobile application for android phone users for reporting adverse medicines reactions; 2017 [Available from: https://www.facebook.com/649850065097471/posts/zamra-has-launched-adra-a-new-mobile-application-for-adroid-phone-users-for-repo/1390732637675873/
- Mohseni A. Doc APProvED: an app that makes identifying pills a snap. Emerg Med News; 2013;35(10):29.
- Tuck C, Maamri A, Chan AHY, Babar Z-U-D. Editorial: medicines pricing, access and safety in Morocco. Tropical Med Int Health. 2019;24(3):260–263
- Bright J. Drone delivery startup Zipline launches UAV medical program in Ghana: Tech Crunch; 2019 [Available from: https://techcrunch.com/2019/04/24/drone-delivery-startup-zipline-launches-uav-medical-program-in-ghana/
- Nunoo C. Use digital system to improve services- Veep tells pharmacists: Graphic Onlin; 2019 [Available from: https://www.graphic.com.gh/news/general-news/ghana-news-use-digital-system-to-improve-services-veep-tells-pharmacists.html
- Zarocostas J. How to fight an infodemic. Lancet. 2020;395(10225):676.
- International Pharmaceutical Federation (FIP). mHealth — Use of mobile health tools in pharmacy practice. The Hague: International Pharmaceutical Federation; 2019.
- Commonwealth Pharmacists Association. Commonwealth Partnerships for Antimicrobial Stewardship London: CPA; 2020 [Available from: https://commonwealthpharmacy.org/commonwealth-partnerships-for-antimicrobial-stewardship/
- Levison L, Fraser HS. Requirements for an Open-Source Pharmacy Dispensing and Stores Management Software Application for Developing Countries. Bellagio, Italy: Making the eHealth Connection Conference; 2008.
- Barnes L, Heithoff DM, Mahan SP, Fox GN, Zambrano A, Choe J, et al. Smartphone-based pathogen diagnosis in urinary sepsis patients. EBioMedicine. 2018;36:73–82.
- D’Ambrosio MV, Bakalar M, Bennuru S, Reber C, Skandarajah A, Nilsson L, et al. Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope. Sci Transl Med. 2015;7(286):286re4 re4.
- International Pharmaceutical Federation (FIP). Report of the International Summit on Medicines Shortages. The Hague: International Pharmaceutical Federation; 2013.
- International Pharmaceutical Federation (FIP). Reporting Medicines Shortages - Models and Tactical options. The Hague: International Pharmaceutical Federation; 2017.
- Lorgelly PK. The impact of Brexit on pharmaceuticals and HTA. PharmacoEconomics - Open. 2018;2(2):87–91.
- Pharmaceutical Society of Ghana, editor. Communiqué issued at the end of the PSGH symposium: Ghana as a pharmaceutical manufacturing hub-the way forward for national development. Pharmaceutical Society of Ghana (PSGH) national symposium; Ghana Academy of Arts and Sciences. 2019.
- B&FT Online. Bawumia Wants Ghana to Become Pharmaceutical R&D Hub in Sub-Region: B&FT Online; 2018 [Available from: https://thebftonline.com/2018/business/bawumia-wants-ghana-to-become-pharmaceutical-rd-hub-in-sub-region/
- Ndomondo-Sigonda M, Ambali A. The African medicines regulatory harmonization initiative: rationale and benefits. Clin Pharmacol Ther. 2011;89(2):176–178.
- African Medicine Agency (AMA) Treaty [press release]. Ethiopia: African Union;2020.
- Baxi SM, Beall R, Yang J, Mackey TK. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications. Glob Health. 2019;15(1):57.
- Silverman R, Keller J, Glassman A, Chalkidou K. Tackling the triple transition in global health procurement. Washington: Center for Global Development; 2019.
- International Pharmaceutical Federation (FIP). FIP Statement of Policy: Environmentally sustainable pharmacy practice. Buenos Aires: Green pharmacy; 2016.
- Bataduwaarachchi VR, Weeraratne CL. Global medication waste management practices: Challenges and opportunities in developing countries. Int J Basic Clin. Pharmacol. 2016;5:2290–4.
- Kamba PF, Ireeta ME, Balikuna S, Kaggwa B. Threats posed by stockpiles of expired pharmaceuticals in low- and middle-income countries: a Ugandan perspective. Bull World Health Organ. 2017;95(8):594–598.
- Kusturica MP, Tomas A, Sabo A. Disposal of unused drugs: Knowledge and behavior among people around the world. InReviews Environ Contam Toxicol. Volume. 2016;240:71–104.
- Karkman A, Do TT, Walsh F, Virta MPJ. Antibiotic-resistance genes in waste water. Trends Microbiol. 2018;26(3):220–228
- Wickware C. Pharmacies across the UK close ‘intermittently’ to cope with increasing pressures from COVID-19: The Pharmaceutical Journal. 2020 [Available from: https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacies-across-the-uk-close-intermittently-to-cope-with-increasing-pressures-from-covid-19/20207844.article
- Gross AE, MacDougall C. Roles of the clinical pharmacist during the COVID‐19 pandemic. Journal of the American College of ClinicalPharmacy. 2020.
- Tsuyuki RT, Beahm NP, Okada H, Al Hamarneh YN. Pharmacists as accessible primary health care providers: review of the evidence. Can Pharm J (Ott). 2018;151(1):4–5.
- Afari-Asiedu S, Kinsman J, Boamah-Kaali E, Abdulai MA, Gyapong M, Sankoh O, et al. To sell or not to sell; the differences between regulatory and community demands regarding access to antibiotics in rural Ghana. J Pharmaceut Policy Pract. 2018;11(1):30.
- Rwanda Community Pharmacists’ Union. Rwanda Community Pharmacists Union. Rwanda: RCPU; 2020. [Available from: https://www.rcpu.org.rw/